Autosomal Dominant Polycystic Kidney Disease (ADPKD) Recruiting Phase 4 Trials for Tolvaptan (DB06212)

Also known as: Autosomal Dominant Polycystic Kidney Disease / Polycystic Kidney Disease, Autosomal Dominant / ADPKD (Autosomal Dominant Polycystic Kidney Disease) / ADPKD / Polycystic Kidney, Autosomal Dominant / Autosomal Dominant Polycystic Kidney Disease (ADPKD / Autosomal Dominant Polycystic Kidney / Kidney, Polycystic, Autosomal Dominant / Autosomal Dominant Polycystic Kidney Disease (ADPKD) / Congenital cystic kidney disease NOS / Congenital cystic kidney disease

IndicationStatusPhase
DBCOND0050861 (Autosomal Dominant Polycystic Kidney Disease (ADPKD))Recruiting4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03949894Evaluating the Safety and effectivenesS in Adult KorEaN Patients Treated With Tolvaptan for Management of Autosomal domInAnt poLycystic Kidney DiseaseTreatment